Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto M Martelli

Showing results (11-20 of 213) with videos related to

Pageof 22
Sort By:
Biochimica Et Biophysica Acta|April 1, 2006
Nuclear protein kinase CAlberto M Martelli, Camilla Evangelisti, Maria Nyakern, et al.
Biochimica Et Biophysica Acta|October 19, 2002
The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger systemLuca M Neri, Paola Borgatti, Silvano Capitani, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 15, 2021
Regulation of p53 and NF-κB transactivation activities by DGKζ in catalytic activity-dependent and -independent mannersToshiaki Tanaka, Tomoyuki Nakano, Yasukazu Hozumi, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|May 4, 2020
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?Luca Braglia, Manuela Zavatti, Marco Vinceti, et al.
Oncotarget|April 14, 2011
Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicityLinda S Steelman, Alberto M Martelli, Ferdinando Nicoletti, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 22, 2019
Nucleosome assembly proteins NAP1L1 and NAP1L4 modulate p53 acetylation to regulate cell fateToshiaki Tanaka, Yasukazu Hozumi, Alberto M Martelli, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|December 30, 2019
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancerCamilla Evangelisti, Francesca Chiarini, Francesca Paganelli, et al.
Cell Cycle (Georgetown, Tex.)|April 4, 2009
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancersAlessandra Cappellini, Francesca Chiarini, Andrea Ognibene, et al.
Cell Cycle (Georgetown, Tex.)|May 28, 2013
Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patientsAlberto M Martelli, Annalisa Lonetti, Sergio Amadori, et al.
Cancers|November 28, 2013
The emerging role of the phosphatidylinositol 3-kinase/ akt/mammalian target of rapamycin signaling network in cancer stem cell biologyAlberto M Martelli, Camilla Evangelisti, Francesca Chiarini, et al.
Pageof 22

Showing results (11-20 of 213) with videos related to

Sort By:
Pageof 22
Biochimica Et Biophysica Acta|April 1, 2006
Nuclear protein kinase CAlberto M Martelli, Camilla Evangelisti, Maria Nyakern, et al.
Biochimica Et Biophysica Acta|October 19, 2002
The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger systemLuca M Neri, Paola Borgatti, Silvano Capitani, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 15, 2021
Regulation of p53 and NF-κB transactivation activities by DGKζ in catalytic activity-dependent and -independent mannersToshiaki Tanaka, Tomoyuki Nakano, Yasukazu Hozumi, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|May 4, 2020
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?Luca Braglia, Manuela Zavatti, Marco Vinceti, et al.
Oncotarget|April 14, 2011
Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicityLinda S Steelman, Alberto M Martelli, Ferdinando Nicoletti, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 22, 2019
Nucleosome assembly proteins NAP1L1 and NAP1L4 modulate p53 acetylation to regulate cell fateToshiaki Tanaka, Yasukazu Hozumi, Alberto M Martelli, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|December 30, 2019
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancerCamilla Evangelisti, Francesca Chiarini, Francesca Paganelli, et al.
Cell Cycle (Georgetown, Tex.)|April 4, 2009
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancersAlessandra Cappellini, Francesca Chiarini, Andrea Ognibene, et al.
Cell Cycle (Georgetown, Tex.)|May 28, 2013
Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patientsAlberto M Martelli, Annalisa Lonetti, Sergio Amadori, et al.
Cancers|November 28, 2013
The emerging role of the phosphatidylinositol 3-kinase/ akt/mammalian target of rapamycin signaling network in cancer stem cell biologyAlberto M Martelli, Camilla Evangelisti, Francesca Chiarini, et al.
Pageof 22